Association Between Neutrophil Percentage‐to‐Albumin Ratio (NPAR) and Risk of Stroke in Patients With Hypertension: A Cohort Study
The Journal of Clinical Hypertension · 2026
DOI: 10.1111/jch.70200 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Clinical Hypertension, 2026. Verfasst von Leyi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Stroke, Hypertension, Neutrophils, Serum Albumin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Projects of National Natural Science Foundation of China, Capital's Funds for Health Improvement and Research.
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke is a leading cause of disability among hypertensive adults, with notable sex differences in risk and outcomes. Neutrophil percentage‐to‐albumin ratio (NPAR) is an easily obtainable composite index of systemic inflammation with prognostic value in cardiovascular disease, but its utility for primary stroke prevention in hypertension remains unclear. We therefore examined the association of NPAR with first stroke in hypertensive adults and tested for sex‐specific effects. We analyzed 13 848 participants from the China Stroke Primary Prevention Trial. NPAR was calculated as the neutrophil percentage (%) × 100/albumin (g/dL). Cox proportional hazards models evaluated the association between NPAR and first stroke, and subgroup analyses assessed sex‐specific effects. During a median follow‐up of 4.5 years, 371 participants (2.7%) experienced stroke. The risk of stroke was significantly higher in Q2, Q3, and Q4 than in Q1 (HR 1.76, 95% CI 1.31–2.36, p < 0.001 [Q2], HR 1.54, 95% CI 1.14–2.08, p = 0.005 [Q3], and HR 1.57, 95% CI 1.17–2.12, p = 0.003 [Q4] in the adjusted model). The result remained consistent when the Q2 to Q4 groups were combined and compared with the Q1 group. Subgroup analysis revealed a significant sex difference, with higher NPAR associated with increased stroke risk in women but not in men ( p = 0.035). These findings suggest that higher NPAR independently predicts stroke risk in patients with hypertension, with a substantially stronger association in women, and highlight sex‐specific inflammatory mechanisms and the potential of NPAR as a biomarker for female‐focused prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Peking University First Hospital, Beijing, China.
- Institute of Cardiovascular Disease, Peking University First Hospital, Beijing, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
- NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University, Beijing, China.
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Projects of National Natural Science Foundation of China
- Capital's Funds for Health Improvement and Research
Zitieren
APA
Wang, L., Liu, Z., Zhang, N., Zhang, L., Liu, X., Fan, F., Zhang, Y., & Li, J. (2026). Association Between Neutrophil Percentage‐to‐Albumin Ratio (NPAR) and Risk of Stroke in Patients With Hypertension: A Cohort Study. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70200
Vancouver
Wang L, Liu Z, Zhang N, Zhang L, Liu X, Fan F, et al. Association Between Neutrophil Percentage‐to‐Albumin Ratio (NPAR) and Risk of Stroke in Patients With Hypertension: A Cohort Study. The Journal of Clinical Hypertension. 2026. doi:10.1111/jch.70200
BibTeX
@article{Wang2026,
author = {Wang, Leyi and Liu, Zhihao and Zhang, Nan and Zhang, Long and Liu, Xu and Fan, Fangfang and Zhang, Yan and Li, Jianping},
title = {Association Between Neutrophil Percentage‐to‐Albumin Ratio (NPAR) and Risk of Stroke in Patients With Hypertension: A Cohort Study},
journal = {The Journal of Clinical Hypertension},
year = {2026},
doi = {10.1111/jch.70200}
}
EUVIMED